Par Pharmaceutical Companies Inc. is buying JHP Group Holdings.

JHP, headquartered in Parsippany, N.J., is the parent company of JHP Pharmaceuticals, a specialty pharmaceutical company that develops, manufactures and markets branded and generic injectable products. The company’s medications include Aplisol, which helps diagnose tuberculosis, and Adrenalin, an epinephrine shot. Terms of the deal were not immediately disclosed, but Par says it will file a form with the U.S. Securities and Exchange Commission that will contain more details.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.